Plain-English translation of NCT06745778 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how a new type of pacing lead—called a left bundle branch pacing lead—works inside heart devices that are designed to prevent dangerous heart rhythms. Researchers will record the electrical signals from your heart device during normal activities and light exercise over the first 6 months after your implant to see if the new lead provides accurate and stable information.
Heart devices need to reliably detect dangerous heart rhythms to work properly and keep patients safe. This study is checking whether the new pacing lead design can provide clear, consistent electrical readings from your heart in real-world conditions—not just in the hospital.
You will wear a portable heart monitor (similar to a Holter monitor) at the time of your implant and again at follow-up visits over 6 months. During these monitoring sessions, the device will record your heart's electrical signals while you rest, walk around, and sometimes during gentle pacing tests. Most of your participation happens during your regular clinic visits; there are no extra medications or procedures beyond standard care.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
China
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Enrollment target
~50 participants
Started
February 2025
Primary completion
August 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.